SM

Shahzad Malik

General Partner at Advent Life Sciences

London, England

Investor
VC

Invests in

Locations:

London

  • Min Investment:

    $25,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,000,000.00

Skills

Venture Capital
Private Equity
Start-ups
Growth Capital
Entrepreneurship
Mergers
Corporate Development
Lifesciences
Biotechnology
Valuation
Commercialization
Investor Relations
Emerging Markets
IPO
Medical Devices
Board of Directors
Joint Ventures
Capital Raising
Angel Investing
Deal Sourcing

Education

Lists including Shahzad

AT
AS
AT
AH

All Series A Investors

14752 people

Investments

Moximed

Series C

Total Funding: $200M

MiroBio

Series A

Total Funding: $130M

Wondr Medical

Seed

Total Funding: $15M

Proximie

Series C

Total Funding: $120M

Acutus Medical

Series A

Total Funding: $110M

Versartis

Series B

Total Funding: $130M

Conatus Pharmaceuticals

Series A

Total Funding: $50M

Work Experience

Advent Life Sciences LLP

1999

  • General Partner

    1999

MQ: Transforming Mental Health

2019

  • Chair Of The Board Of Trustees

    2019

McKinsey & Company

1997 - 1999

  • Associate

    1997 - 1999

NHS

1991 - 1997

  • Interventional Cardiologist

    1991 - 1997